Blogs
Multistakeholder collaboration, led by Catalyst Healthcare Consulting, to recommend Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (preprint).
Read more
Catalyst to Moderate DIA 2025 Panel on Enhancing Innovation in CGT Clinical Trials for Rare Disease
Join us for this dynamic conversation on Monday, June 16th, from 2:15–3:15 PM at DIA. We’d love to connect if you’ll be attending!
Read more
Catalyst to attend FDLI 2025 Annual Conference
If you are attending the FDLI conference, we would love to chat - reach out to us on LinkedIn!
Read more
Catalyst advances women’s health in new LinkedIn article
On Tuesday, Catalyst’s Taryn Serman and Nancy Myers, together with industry leaders, published the following article regarding women’s health on LinkedIn.
Read more
Government Shutdown 101: What to Expect
March 14th is approaching fast, and it increasingly looks like politicians are driving us toward another government shutdown.
Read more
Expected FDA Impact of a Government Shutdown
Critically, the critical public health mission and user fees are the buffer for FDA when a shutdown occurs. Below, we will delve into how a shutdown may look for the FDA under the Trump administration.
Read more
